Connect your AI

Disc Medicine IRON Accrued liabilities

Accrued liabilities at other companies

Bristol-Myers SquibbBMY

-$3.5B-457%

Other financials

Income statement

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

Market cap$2.69B+42.2%

Returns & leverage

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Disc Medicine's accrued liabilities?: Disc Medicine (IRON) reported accrued liabilities of -$8.73M in Q1 2026.
How has Disc Medicine's accrued liabilities changed year-over-year?: Disc Medicine's accrued liabilities decreased by 136.8% year-over-year, from -$3.69M to -$8.73M.